[A2k] [Ip-health] Act Up-Paris statement on the TRIPS Council decision

Matthew Kavanagh matthew at healthgap.org
Wed Jun 12 06:27:42 PDT 2013


While that's true, there is still some wording which seems conditional and
my understanding is that there will still be an opportunity to extend the
2016 unconditional extension on pharmaceutical patents, since the language
said it did not prejudice such discussions. Yes?


On Wed, Jun 12, 2013 at 8:31 AM, Ellen 't Hoen <ellenthoen.ip at gmail.com>wrote:

> That is my reading too.
>
> There seems to be some confusion about how the recent draft decision of
> the WTO Council for TRIPS to extend the Least Developing Country Members
> obligation to comply with TRIPS until at least 1st July 2021 relates to the
> 2002 TRIPS Council decision which specifically removed any obligation for
> LDCs to comply with Section 5 (Patents) and Section 7 (Protection of
> Undisclosed Information) of Part II of TRIPS, including any obligation to
> enforce rights under these provisions, until 1st January 2016.
>
>
>
> The extension agreed upon last week concerns to the entire TRIPS Agreement
> (with the exception of  articles 3, 4 and 5 related to national treatment
> and most-favored nation treatment) and thus removes also LDCs obligations
> with regards to pharmaceutical patents and data protection until at least
> 2021.
>
>
>
> It is also important to note that the decision does not include any more
> the ‘no roll’back’ language of the earlier extension decision of 2005,
> which read:
>
> “Least-developed country Members will ensure that any changes in their
> laws, regulations and practice made during the additional transitional
> period do not result in a lesser degree of consistency with the provisions
> of the TRIPS Agreement.”
>
>
>
> This means that LDCs are now free to make legislative changes that fit
> their own policy and technological development objectives, including
>  developing the types of IP provisions that fit their specific needs.
>
>
>
> The specific pharmaceutical waiver of 2002 which runs until 1st January
> 2016, could however be subject to a different extension request regardless
> –– such an extension could for example go well beyond 2021 and survive for
> example in the case 2021 no further general extension is requested or
> granted. I assume LDCs will make such a request.
>
> -----------------------------------------
> Ellen 't Hoen
> phone: +33695048388
> e-mail: ellenthoen.ip at gmail.com
> twitter:@ellenthoen
> skype: efmthoen
>
>
>
> On 12 Jun 2013, at 14:18, Jamie Love <james.love at keionline.org> wrote:
>
> > Perhaps others can clarify, but it is my understanding that the
> > current TRIPS extension until 2021 covers all TRIPS obligations,
> > including pharmaceutical patents and test data, but also that there
> > will be a discussion about a separate extension of the pharmaceutical
> > patents and test data and one possible outcome of that discussion will
> > be a longer or even more permanent extension of the drug patent and
> > test data issues.
> >
> > http://www.bls.gov/oes/current/naics5_512130.htm#00-0000
> >
> > 2013/6/11 Céline Grillon <international at actupparis.org>:
> >>
> >> Communiqué de presse - Act Up-Paris - Mardi 11 juin 2013
> >>
> >> Droits de « propriété intellectuelle »
> >> L'OMC accorde un délais de grâce supplémentaire aux pays pauvres
> >>
> >>
> >> Après un bras de fer de plusieurs semaines avec les pays riches, les
> Pays
> >> les Moins Avancés (PMA) ont finalement obtenu un délais supplémentaire
> de 8
> >> ans pour appliquer l'Accord sur aspects des droits de propriété
> >> intellectuelle qui touchent au commerce (ADPIC) qui fixe les règles
> >> internationales de protection de la « propriété intellectuelle ».
> >>
> >> "C'est une victoire en demi-teinte" analyse Céline Grillon, responsable
> du
> >> plaidoyer international à Act Up-Paris, "les PMA demandaient une
> extension
> >> de cette période sans condition de durée, jusqu'à ce qu'ils sortent de
> la
> >> catégorie des pays les plus pauvres, dans la mesure où l'application de
> ces
> >> règles mettrait en péril leur développement technologique et industriel
> déjà
> >> précaire". Une avancée par rapport à la situation précédente reste
> néanmoins
> >> la suppression de l'obligation de conserver les règles déjà existantes.
> >>
> >> Act Up-Paris dénonce les pressions exercées par les Etats-Unis et
> l'Union
> >> européenne lors des consultations informelles dont ont été exclus les
> pays à
> >> revenu intermédiaire favorables à la demande des PMA tels que le Brésil
> ou
> >> l'Inde. La prolongation de la période de transition est un droit
> >> expressément conféré aux PMA par l'ADPIC, elle n'aurait pas dû être
> assortie
> >> de délais.
> >>
> >>
> >> Act Up-Paris s'inquiète en outre que cette prolongation ne concerne pas
> les
> >> produits pharmaceutiques pour lesquels la dérogation court jusqu'en
> 2016. Il
> >> faudra que les PMA exigent une prolongation inconditionnelle, sans quoi
> >> l'accès aux médicaments génériques sera fortement compromis, faisant
> >> craindre une catastrophe sanitaire (cf.
> >> <<http://www.actupparis.org/spip.php?article5119>>).
> >> _______________________________________________
> >> Ip-health mailing list
> >> Ip-health at lists.keionline.org
> >>
> http://lists.keionline.org/mailman/listinfo/ip-health_lists.keionline.org
> >
> >
> >
> > --
> > James Love.  Knowledge Ecology International
> > http://www.keionline.org, +1.202.332.2670, US Mobile: +1.202.361.3040,
> > Geneva Mobile: +41.76.413.6584, efax: +1.888.245.3140.
> > twitter.com/jamie_love
> >
> > _______________________________________________
> > Ip-health mailing list
> > Ip-health at lists.keionline.org
> >
> http://lists.keionline.org/mailman/listinfo/ip-health_lists.keionline.org
>
> _______________________________________________
> Ip-health mailing list
> Ip-health at lists.keionline.org
> http://lists.keionline.org/mailman/listinfo/ip-health_lists.keionline.org
>



-- 
Matthew  Kavanagh
Health GAP (Global Access Project)
tel +1 202 355-6343 // mob +1 202 486-2488
matthew at healthgap.org
   www.healthgap.org

@kavanaghmm

*Join us on Friday, June 14th*
*2013 Health GAP Global Health Justice Awards*
*buy tix and ads: www.healthgap.org*



More information about the A2k mailing list